SLS Management’s Bausch Health BHC Stock Holding History

SLS Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-179,900	Closed	-$1.98M	–	14
2017 Q1	$1.98M	Buy	+179,900	New	+$2.47M	2.76%	10

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SLS Management's BHC Position: Q2 2017 in Review

SLS Management sold out of Bausch Health (BHC) in Q2 2017, closing a stake of 179,900 shares — an estimated $1.98M sold.

SLS Management first reported a position in BHC in Q1 2017 and held it in 1 quarter. The position peaked at $1.98M in Q1 2017. 317 funds tracked by Wall St. Rank hold BHC as of Q2 2017.

SLS Management reported no remaining Bausch Health position as of Q2 2017 after selling out during the quarter.
SLS Management sold 179,900 Bausch Health shares in Q2 2017, an estimated $1.98M.
SLS Management first reported a position in Bausch Health in Q1 2017 and held it in 1 quarter.
SLS Management's Bausch Health position peaked at $1.98M in Q1 2017.
317 funds tracked by Wall St. Rank held Bausch Health as of Q2 2017.

Based on SLS Management's 13F filing for Q2 2017, filed 10 Aug 2017.